Alliance EAY191-A6: FOLFOX in Combination with Binimetinib as 2nd-Line Therapy for Patients with Advanced Biliary Tract Cancers (BTCs) with MAPK Pathway Alterations: A ComboMATCH Treatment Trial
- Citation:
- J Clin Oncol vol 24 (16_suppl) TPS4196
- Meeting Instance:
- ASCO 2024
- Year:
- 2024
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- No-Endpoint
- Analysis:
- Trial-Description-Only
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- epub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- None
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- GI
- Pharmas:
- Grants:
- U10CA180821, U10CA180882; U10CA180820 (ECOG-ACRIN); U10CA180868 (NRG); U10CA180888 (SWOG);
- Corr. Author:
- Authors:
- Ardaman Shergill Chih-Yi Liao Mohamed I. Elsaid Tareq Al Baghdadi Yan Ji Diane Feldman Suzanne George Eileen M. O'Reilly Jeffrey Meyerhardt Stephanie Berg Gary Schwartz Pamela Munster Tanios Bekaii-Saab Ghassan K. Abou-Alfa Rachna Shroff Geoffrey Shapiro
- Networks:
- CA136, COLUMBIA, LAPS-IL057, LAPS-MA036, LAPS-MN026, LAPS-NY016, MCRC, METROMIN
- Study
- Alliance-EAY191-A6
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: